Lista de obras - Manuel Romero-Gomez - Dominio Público Uruguay

A Pilot Study of Serum Sphingomyelin Dynamics in Subjects with Severe Obesity and Non-alcoholic Steatohepatitis after Sleeve Gastrectomy

scientific article published on 01 March 2019

A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin.

artículo científico publicado en 2016

A new therapeutic scene in the treatment of the chronic hepatitis for virus C

artículo científico publicado el 1 de noviembre de 2012

A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTR

article

A real life study of Helicobacter pylori eradication with bismuth quadruple therapy in naïve and previously treated patients.

artículo científico publicado en 2017

A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms

scientific article published in Scientific Reports

ABIDE: an accurate predictive model of liver decompensation in patients with non-alcoholic fatty liver-related cirrhosis

scientific article published on 25 September 2020

APOC3 polymorphisms and non-alcoholic fatty liver disease: Resolving some doubts and raising others ⬇️

artículo científico publicado el 23 de junio de 2011

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.

artículo científico publicado en 2016

Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

artículo científico publicado en 2021

Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting: The MENTE Study.

artículo científico publicado en 2016

Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy.

artículo científico publicado en 2002

An extra virgin olive oil rich diet intervention ameliorates the nonalcoholic steatohepatitis induced by a high-fat "Western-type" diet in mice.

artículo científico publicado en 2016

Analysis of the burden and variability in the management of NAFLD patients in the clinical practice: unifying the required criteria

scientific article published on 01 April 2019

Antiphospholipid antibodies are related to portal vein thrombosis in patients with liver cirrhosis

scientific article published on 01 October 2000

Assessing cardiovascular risk in hepatitis C: An unmet need

artículo científico publicado en 2015

Association between vitamin D and hepatitis C virus infection: a meta-analysis

artículo científico publicado en 2013

Bacterial antigen translocation and age as BMI-independent contributing factors on systemic inflammation in NAFLD patients

scientific article published on 19 June 2020

Cardiotrophin-1 is an anti-inflammatory cytokine and promotes IL-4-induced M2 macrophage polarization

scientific article published on 20 March 2019

Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do

artículo científico publicado en 2017

Case Report: Acute-on-Chronic Liver Failure: Making the Diagnosis between Infection and Acute Alcoholic Hepatitis.

artículo científico publicado en 2016

Community-acquired pneumonia during the first post-pandemic influenza season: a prospective, multicentre cohort study.

artículo científico publicado en 2013

Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline.

artículo científico publicado en 2018

Correction for Quer at al., High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current Methods

artículo científico publicado en 2016

Critical flicker frequency: it is time to break down barriers surrounding minimal hepatic encephalopathy

artículo científico publicado en 2007

Cronkhite-Canada syndrome: a new case report of this enigmatic and infrequent disease

scientific article published on 01 March 2010

Cutaneous lymphoma in a patient with ulcerative colitis after immunosuppressive therapy ⬇️

artículo científico publicado el 18 de mayo de 2011

Deciphering the spectrum of low-grade hepatic encephalopathy in clinical practice

artículo científico publicado en 2014

Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury.

artículo científico publicado en 2016

Detecting liver fat from viscoelasticity: How good is CAP in clinical practice? The need for universal cut-offs

artículo científico publicado en 2017

Development and Validation of Hepamet Fibrosis Scoring System A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis

scientific article published on 11 June 2019

Development and validation of a noninvasive prediction model for nonalcoholic steatohepatitis resolution after lifestyle intervention.

artículo científico publicado en 2016

Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis

artículo científico publicado en 2018

Different approaches to therapy of esophageal granular cell tumor (Abrikossoff tumor)

artículo científico publicado en 2006

Does the Antitumor Necrosis Factor-α Therapy Decrease the Vertebral Fractures Occurrence in Inflammatory Bowel Disease?

scientific article published on 13 August 2018

Duration of the acute hepatic encephalopathy episode determines survival in cirrhotic patients

artículo científico publicado en 2017

Editorial: looking for patients at risk of cirrhosis in the general population-many needles in a haystack

artículo científico publicado en 2018

Effect of Quercetin on Hepatitis C Virus Life Cycle: From Viral to Host Targets

artículo científico publicado en 2016

Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months

artículo científico publicado en 2017

Effectiveness and safety of elbasvir/grazoprevir therapy in patients with chronic HCV infection: Results from the Spanish HEPA-C real-world cohort

artículo científico publicado en 2018

Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease

artículo científico publicado en 2018

Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

artículo científico publicado en 2016

Endoscopic closure of a rectovaginal fistula combiningN-2-butyl-cyanoacrylate (Histoacryl) and Resolution clips ⬇️

artículo científico publicado el 18 de marzo de 2011

Entry of hepatitis C virus into the cell: A therapeutic target ⬇️

artículo científico publicado el 7 de septiembre de 2012

Epigenetic mechanisms in non-alcoholic fatty liver disease: An emerging field

artículo científico publicado en 2015

Erratum to: Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months

artículo científico publicado en 2017

Evolution of the incidence of inflammatory bowel disease in Southern Spain.

artículo científico

Experimental models for hepatic encephalopathy.

artículo científico

Familial Mediterranean fever mimicking Fitz-Hugh-Curtis syndrome

artículo científico publicado en 2003

Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient-Reported Outcomes

artículo científico publicado en 2020

Fatigue is associated with high circulating leptin levels in chronic hepatitis C.

artículo científico publicado en 2003

Fe de errores de «Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica» [Gastroenterol Hepatol. 2018;41(5):328-349]

scientific article published on 01 August 2018

Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients

artículo científico publicado en 2016

FibroGENE: A gene-based model for staging liver fibrosis

artículo científico publicado en 2015

Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study

artículo científico publicado en 2018

Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection

artículo científico publicado en 2015

Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment.

artículo científico publicado en 2011

Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury.

artículo científico publicado en 2008

HAVCR1 gene haplotypes and infection by different viral hepatitis C virus genotypes

artículo científico publicado en 2011

Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic Inflammation

artículo científico publicado en 2018

Hepatic encephalopathy and traffic accidents: Vigilance is needed!

artículo científico publicado en 2019

Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure

artículo científico publicado en 2015

Hepatitis B and NAFLD: Lives Crossed

artículo científico publicado en 2017

Hepatitis C Virus: Current and Evolving Treatments for Genotypes 2 and 3.

artículo científico publicado en 2015

Hepatitis C virus deep sequencing for sub-genotype identification in mixed infections: A real-life experience

artículo científico publicado en 2017

Hepatitis C: are there any options for non-responders?

artículo científico publicado en 2005

Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.

artículo científico publicado en 2013

High Prevalence of Ibuprofen Drug-Induced Liver Injury in Spanish and Latin-American Registries.

artículo científico publicado en 2017

High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain.

artículo científico publicado en 2015

High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4.

artículo científico publicado en 2017

High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods

artículo científico publicado en 2015

Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD)

scientific article published on 01 April 2019

IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis

artículo científico publicado en 2017

Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease

artículo científico publicado en 2016

Impact of comorbidities on patients outcomes after interferon-free therapy-induced viral eradication in hepatitis

artículo científico publicado en 2017

Impaired glucose metabolism increases risk of hepatic decompensation and death in patients with compensated hepatitis C virus-related cirrhosis.

artículo científico publicado en 2015

Importance of Host Genetic Factors HLA and IL28B as Predictors of Response to Pegylated Interferon and Ribavirin ⬇️

artículo científico publicado el 14 de junio de 2011

Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis.

artículo científico publicado en 2016

Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study.

artículo científico publicado en 2016

Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease.

artículo científico publicado en 2013

Infliximab induces remission of pyoderma gangrenosum

artículo científico publicado en 2002

Influence of non-alcoholic fatty liver disease on cardiovascular disease

artículo científico publicado en 2012

Insulin resistance and response to antiviral therapy in chronic hepatitis C: mechanisms and management.

artículo científico publicado en 2010

Insulin resistance and sustained virological response in hepatitis C: from bench to bedside ⬇️

artículo científico publicado el 9 de noviembre de 2010

Insulin resistance as a non-invasive method for the assessment of fibrosis in patients with hepatitis C: a comparative study of biochemical methods

artículo científico publicado en 2006

Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism ⬇️

artículo científico publicado el 5 de noviembre de 2012

Insulin resistance, telaprevir, and virological response in hepatitis C: the debate must go on.

artículo científico publicado en 2013

Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.

artículo científico publicado en 2015

Introduction

artículo científico publicado en 2013

Irisin, a link among fatty liver disease, physical inactivity and insulin resistance

artículo científico publicado en 2014

Killer Immunoglobulin-Like Receptor Profiles Are not Associated with Risk of Amoxicillin-Clavulanate-Induced Liver Injury in Spanish Patients

artículo científico publicado en 2016

Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy

artículo científico publicado en 2016

Long-term follow-up of patients with chronic hepatitis C treated with α-interferon and ribavirin antiviral therapy: clinical and fibrosis impact of treatment response.

artículo científico publicado en 2017

Low phase angle is associated with the development of hepatic encephalopathy in patients with cirrhosis.

artículo científico publicado en 2016

Macro-AST as cause of unknown hypertransaminasaemia.

artículo científico publicado en 2003

Management of anemia induced by triple therapy in patients with chronic hepatitis C: challenges, opportunities and recommendations.

artículo científico

Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models

artículo científico publicado en 2019

Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis.

artículo científico publicado en 2017

Meta‐analysis: insulin resistance and sustained virological response in hepatitis C ⬇️

artículo científico publicado el 29 de mayo de 2011

Meta‐analysis: pegylated interferon α‐2a achieves higher early virological responses than α‐2b in chronic hepatitis C ⬇️

artículo científico publicado el 14 de abril de 2013

Metformin modifies glutamine metabolism in an in vitro and in vivo model of hepatic encephalopathy

artículo científico publicado en 2018

Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis

artículo científico publicado en 2015

Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression.

artículo científico publicado en 2017

Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injury.

artículo científico publicado en 2010

Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030

article

Modulation of host lipid metabolism by hepatitis C virus: Role of new therapies

artículo científico publicado en 2015

Monitoring activities and improvement in the use of antibiotics in Spanish hospitals: results of a national survey

artículo científico publicado en 2011

Natural Extracts Abolished Lipid Accumulation in Cells Harbouring non-favourable PNPLA3 genotype

artículo científico publicado en 2018

New therapeutic perspectives in non-alcoholic steatohepatitis

artículo científico publicado en 2017

Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates

artículo científico publicado en 2018

Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials

artículo científico publicado en 2019

Normality tables in the Spanish population for psychometric tests used in the diagnosis of minimal hepatic encephalopathy

artículo científico publicado en 2006

Oral glutamine challenge is a marker of altered ammonia metabolism and predicts the risk of hepatic encephalopathy

artículo científico publicado en 2019

Ornithine phenylacetate targets alterations in the expression and activity of glutamine synthase and glutaminase to reduce ammonia levels in bile duct ligated rats.

artículo científico publicado en 2013

Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients

artículo científico publicado en 2016

Peer-to-Peer Sessions in Primary Care to Improve the Hepatitis B Detection Rate in Seville, Spain

article

Pharmacoeconomic analysis of the treatment of chronic hepatitis C with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin in Spain

artículo científico publicado en 2013

Pharmacogenetics of ribavirin-induced anemia in hepatitis C.

artículo científico publicado en 2016

Pharmacotherapy of hepatic encephalopathy in cirrhosis.

artículo científico publicado en 2010

Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim study.

artículo científico publicado en 2015

Preemptive‐TIPS Improves Outcome in High‐Risk Variceal Bleeding: An Observational Study

artículo científico publicado en 2018

Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin.

artículo científico

Primary biliary cholangitis in Spain. Results of a Delphi study of epidemiology, diagnosis, follow-up and treatment

article

Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy.

artículo científico publicado en 2004

Pseudomembranous colitis induced by diclofenac

artículo científico publicado en 1998

Randomized clinical trial comparing high versus standard dose of ribavirin plus peginterferon alfa-2a in hepatitis C genotype 3 and high viral load. Dargen-3 study.

artículo científico publicado en 2013

Re: Unsedated colonoscopy: an option for some but not for all

artículo científico publicado en 2012

Recommendations for management and treatment of nonalcoholic steatohepatitis

article

Relationship Between Self-Perceived Health, Vitality, and Posttraumatic Growth in Liver Transplant Recipients

scientific article published on 11 June 2019

Relationship between H. pylori and hepatitis A virus infection.

artículo científico publicado en 2012

Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practice.

artículo científico publicado en 2016

Reply

artículo científico publicado en 2016

Reply: To PMID 25865049.

artículo científico publicado en 2015

Results of a survey about specific inflammatory bowel disease units in Andalusia

scientific article published on 01 March 2009

Review article: HCV genotype 3 – the new treatment challenge

artículo científico publicado en 2014

Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment.

artículo científico publicado en 2015

Role of assessing liver fibrosis in management of chronic hepatitis C virus infection

artículo científico publicado en 2016

Role of diabetes mellitus on hepatic encephalopathy ⬇️

artículo científico publicado el 24 de noviembre de 2012

Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis

artículo científico publicado en 2014

Sarcoidosis, sclerosing cholangitis, and chronic atrophic autoimmune gastritis: a case of infiltrative sclerosing cholangitis

scientific article published on 01 September 1998

Serum lipidome unravels a diagnostic potential in bile acid diarrhoea

artículo científico publicado en 2023

Serum selenium levels and oxidative balance as differential markers in hepatic damage caused by alcohol.

artículo científico publicado en 2013

Simeprevir in combination with sofosbuvir in treatment-naïve and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study (PLUTO).

artículo científico publicado en 2016

Simple non‐invasive scoring systems and histological scores in predicting mortality in patients with non‐alcoholic fatty liver disease: A systematic review and meta‐analysis

artículo científico publicado en 2021

Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy

artículo científico publicado en 2018

Sofosbuvir modulates the intimate relationship between hepatitis C virus and lipids.

artículo científico publicado en 2015

Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results

artículo científico publicado en 2017

TLL1 rs17047200 Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C.

artículo científico publicado en 2017

Thalidomide with peginterferon alfa-2b and ribavirin in the treatment of non-responders genotype 1 chronic hepatitis C patients: proof of concept ⬇️

artículo científico publicado el 1 de diciembre de 2011

The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma

artículo científico publicado en 2021

The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity

scientific article published on 23 October 2018

The role of nutrition in non-alcoholic fatty liver disease: Pathophysiology and management

scientific article published on 01 February 2020

Three‐day intravenous triple therapy is not effective for the eradication of Helicobacter pyloriinfection in patients with bleeding gastro‐duodenal ulcer ⬇️

artículo científico publicado el 15 de noviembre de 2003

Treatment of NAFLD with diet, physical activity and exercise.

artículo científico publicado en 2017

Triple therapy in cirrhotic patients and those with advanced fibrosis: relevant aspects in clinical practice

artículo científico publicado en 2014

Use of HOMA-IR in hepatitis C ⬇️

artículo científico publicado el 25 de mayo de 2011

Use of Steatotic Grafts in Liver Transplantation: Current Status

scientific article published on 05 April 2019

Usefulness of bioelectrical impedance analysis for monitoring patients with refractory ascites

artículo científico publicado en 2019

Variations in the promoter region of the glutaminase gene and the development of hepatic encephalopathy in patients with cirrhosis: a cohort study

artículo científico publicado en 2010

Water-soluble extracts from edible mushrooms (Agaricus bisporus) as inhibitors of hepatitis C viral replication

scientific article published on 01 June 2019

Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis

artículo científico publicado en 2015

[Caecal granular cell tumours and Crohn's disease]

artículo científico publicado en 2007

[Portal thrombosis: beyond liver cirrhosis]

artículo científico publicado en 2014

[Pseudomembranous colitis of unusual origin]

scientific article published on 01 June 2008

miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis

artículo científico publicado en 2018

Lista de obras de Manuel Romero-Gomez

A Pilot Study of Serum Sphingomyelin Dynamics in Subjects with Severe Obesity and Non-alcoholic Steatohepatitis after Sleeve Gastrectomy

A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin.

A new therapeutic scene in the treatment of the chronic hepatitis for virus C

A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTR

A real life study of Helicobacter pylori eradication with bismuth quadruple therapy in naïve and previously treated patients.

A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms

ABIDE: an accurate predictive model of liver decompensation in patients with non-alcoholic fatty liver-related cirrhosis

APOC3 polymorphisms and non-alcoholic fatty liver disease: Resolving some doubts and raising others ⬇️

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.

Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting: The MENTE Study.

Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy.

An extra virgin olive oil rich diet intervention ameliorates the nonalcoholic steatohepatitis induced by a high-fat "Western-type" diet in mice.

Analysis of the burden and variability in the management of NAFLD patients in the clinical practice: unifying the required criteria

Antiphospholipid antibodies are related to portal vein thrombosis in patients with liver cirrhosis

Assessing cardiovascular risk in hepatitis C: An unmet need

Association between vitamin D and hepatitis C virus infection: a meta-analysis

Bacterial antigen translocation and age as BMI-independent contributing factors on systemic inflammation in NAFLD patients

Cardiotrophin-1 is an anti-inflammatory cytokine and promotes IL-4-induced M2 macrophage polarization

Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do

Case Report: Acute-on-Chronic Liver Failure: Making the Diagnosis between Infection and Acute Alcoholic Hepatitis.

Community-acquired pneumonia during the first post-pandemic influenza season: a prospective, multicentre cohort study.

Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline.

Correction for Quer at al., High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current Methods

Critical flicker frequency: it is time to break down barriers surrounding minimal hepatic encephalopathy

Cronkhite-Canada syndrome: a new case report of this enigmatic and infrequent disease

Cutaneous lymphoma in a patient with ulcerative colitis after immunosuppressive therapy ⬇️

Deciphering the spectrum of low-grade hepatic encephalopathy in clinical practice

Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury.

Detecting liver fat from viscoelasticity: How good is CAP in clinical practice? The need for universal cut-offs

Development and Validation of Hepamet Fibrosis Scoring System A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis

Development and validation of a noninvasive prediction model for nonalcoholic steatohepatitis resolution after lifestyle intervention.

Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis

Different approaches to therapy of esophageal granular cell tumor (Abrikossoff tumor)

Does the Antitumor Necrosis Factor-α Therapy Decrease the Vertebral Fractures Occurrence in Inflammatory Bowel Disease?

Duration of the acute hepatic encephalopathy episode determines survival in cirrhotic patients

Editorial: looking for patients at risk of cirrhosis in the general population-many needles in a haystack

Effect of Quercetin on Hepatitis C Virus Life Cycle: From Viral to Host Targets

Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months

Effectiveness and safety of elbasvir/grazoprevir therapy in patients with chronic HCV infection: Results from the Spanish HEPA-C real-world cohort

Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease

Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

Endoscopic closure of a rectovaginal fistula combiningN-2-butyl-cyanoacrylate (Histoacryl) and Resolution clips ⬇️

Entry of hepatitis C virus into the cell: A therapeutic target ⬇️

Epigenetic mechanisms in non-alcoholic fatty liver disease: An emerging field

Erratum to: Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months

Evolution of the incidence of inflammatory bowel disease in Southern Spain.

Experimental models for hepatic encephalopathy.

Familial Mediterranean fever mimicking Fitz-Hugh-Curtis syndrome

Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient-Reported Outcomes

Fatigue is associated with high circulating leptin levels in chronic hepatitis C.

Fe de errores de «Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica» [Gastroenterol Hepatol. 2018;41(5):328-349]

Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients

FibroGENE: A gene-based model for staging liver fibrosis

Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study

Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection

Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment.

Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury.

HAVCR1 gene haplotypes and infection by different viral hepatitis C virus genotypes

Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic Inflammation

Hepatic encephalopathy and traffic accidents: Vigilance is needed!

Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure

Hepatitis B and NAFLD: Lives Crossed

Hepatitis C Virus: Current and Evolving Treatments for Genotypes 2 and 3.

Hepatitis C virus deep sequencing for sub-genotype identification in mixed infections: A real-life experience

Hepatitis C: are there any options for non-responders?

Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.

High Prevalence of Ibuprofen Drug-Induced Liver Injury in Spanish and Latin-American Registries.

High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain.

High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4.

High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods

Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD)

IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis

Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease

Impact of comorbidities on patients outcomes after interferon-free therapy-induced viral eradication in hepatitis

Impaired glucose metabolism increases risk of hepatic decompensation and death in patients with compensated hepatitis C virus-related cirrhosis.

Importance of Host Genetic Factors HLA and IL28B as Predictors of Response to Pegylated Interferon and Ribavirin ⬇️

Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis.

Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study.